Causal Relationship Between Plasma VEGF Family Proteins and Placenta Previa: A Two-Sample Mendelian Randomization Study

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorGuangzhou Institute of Respiratory Disease

About this trial

This study aims to investigate the causal relationship between plasma vascular endothelial growth factor (VEGF) family proteins and placenta previa using a two-sample Mendelian randomization (MR) approach. Genome-wide association study (GWAS) data will be analyzed to assess the correlation and potential causality between VEGF protein levels and the occurrence of placenta previa.

Eligibility criteria

Qualifiers

Participants included in genome-wide association studies (GWAS) with available data on plasma VEGF family proteins and placenta previa.

Disqualifiers

Participants with incomplete or missing data on plasma VEGF levels or placenta previa.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Guangzhou Institute of Respiratory Disease

Lead sponsor

The Second People's Hospital of Foshan

Collaborator

First People's Hospital of Foshan

Collaborator

Maternal and Child Health Hospital of Foshan

Collaborator